110 related articles for article (PubMed ID: 10825144)
1. Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates.
Cho D; Song H; Kim YM; Houh D; Hur DY; Park H; Yoon D; Pyun KH; Lee WJ; Kurimoto M; Kim YB; Kim YS; Choi I
Cancer Res; 2000 May; 60(10):2703-9. PubMed ID: 10825144
[TBL] [Abstract][Full Text] [Related]
2. IL-18 enhances SCF production of melanoma cells by regulating ROI and p38 MAPK activity.
Hue J; Kim A; Song H; Choi I; Park H; Kim T; Lee WJ; Kang H; Cho D
Immunol Lett; 2005 Jan; 96(2):211-7. PubMed ID: 15585325
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
[TBL] [Abstract][Full Text] [Related]
4. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence.
Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M
Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497
[TBL] [Abstract][Full Text] [Related]
5. Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells.
Lafleur EA; Jia SF; Worth LL; Zhou Z; Owen-Schaub LB; Kleinerman ES
Cancer Res; 2001 May; 61(10):4066-71. PubMed ID: 11358827
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D(3) up-regulating protein 1 (VDUP1) antisense DNA regulates tumorigenicity and melanogenesis of murine melanoma cells via regulating the expression of fas ligand and reactive oxygen species.
Song H; Cho D; Jeon JH; Han SH; Hur DY; Kim YS; Choi I
Immunol Lett; 2003 May; 86(3):235-47. PubMed ID: 12706526
[TBL] [Abstract][Full Text] [Related]
7. Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo.
Rodrigues EG; Garofalo AS; Travassos LR
Cytokines Cell Mol Ther; 2002; 7(3):107-16. PubMed ID: 12850810
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of reactive oxygen species (ROS) and resistance to Fas-mediated apoptosis in the C33A cervical cancer cell line transfected with IL-18 receptor.
Yoon- DY; Cho YS; Park JW; Kim SH; Kim JW
Clin Chem Lab Med; 2004 May; 42(5):499-506. PubMed ID: 15202785
[TBL] [Abstract][Full Text] [Related]
9. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
[TBL] [Abstract][Full Text] [Related]
10. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
Ryan AE; Shanahan F; O'Connell J; Houston AM
Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
[TBL] [Abstract][Full Text] [Related]
11. Involvement of interleukin-6 in the biology and metastatic activity of B16F10 melanoma cells.
García de Galdeano ; Boyano D; Smith-Zubiaga I; Alvarez A; Cantón I; Cañavate L
Eur Cytokine Netw; 1998 Jun; 9(2):187-92. PubMed ID: 9681395
[TBL] [Abstract][Full Text] [Related]
12. IL-12 or IL-15, unlike IL-2, does not interact with histamine in augmenting cytotoxicity of splenocytes against melanoma cells and YAC-1 cells.
Kozar K; Kaminski R; Giermasz A; Basak G; Zagozdzon R; Rybczynska J; Wasik M; Lasek W; Jakobisiak M; Golab J
Oncol Rep; 2002; 9(2):427-31. PubMed ID: 11836621
[TBL] [Abstract][Full Text] [Related]
13. Regulation of IL-18 expression by CRH in mouse microglial cells.
Yang Y; Hahm E; Kim Y; Kang J; Lee W; Han I; Myung P; Kang H; Park H; Cho D
Immunol Lett; 2005 May; 98(2):291-6. PubMed ID: 15860230
[TBL] [Abstract][Full Text] [Related]
14. Direct in vivo transfection of antisense Fas-ligand reduces tumor growth and invasion.
Nyhus JK; Wolford C; Feng L; Barbera-Guillem E
Gene Ther; 2001 Feb; 8(3):209-14. PubMed ID: 11313792
[TBL] [Abstract][Full Text] [Related]
15. IL-2 treatment of B16F10 melanoma cells stimulates metastatic colonization in the liver.
Boyano MD; Garcia de Galdeano A; Smith-Zubiaga I; Cañavate ML
Anticancer Res; 1997; 17(2A):1135-41. PubMed ID: 9137461
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
Oniki S; Nagai H; Horikawa T; Furukawa J; Belladonna ML; Yoshimoto T; Hara I; Nishigori C
Cancer Res; 2006 Jun; 66(12):6395-404. PubMed ID: 16778218
[TBL] [Abstract][Full Text] [Related]
17. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
Li Q; Nakadai A; Takeda K; Kawada T
Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 2A modulates the proliferation of human multiple myeloma cells via regulation of the production of reactive oxygen intermediates and anti-apoptotic factors.
Kang HS; Choi I
Cell Immunol; 2001 Oct; 213(1):34-44. PubMed ID: 11747354
[TBL] [Abstract][Full Text] [Related]
19. Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells.
Lu C; Sheehan C; Rak JW; Chambers CA; Hozumi N; Kerbel RS
Clin Cancer Res; 1996 Aug; 2(8):1417-25. PubMed ID: 9816316
[TBL] [Abstract][Full Text] [Related]
20. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
Sun R; Li AL; Wei HM; Tian ZG
Cell Res; 2004 Feb; 14(1):67-73. PubMed ID: 15040892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
